valproic acid
PolandDrugs containing this active substance
-
The medicine is used in the treatment of epilepsy (various forms) and mania occurring in bipolar affective disorder.
Form: capsules, soft gelatin
Active substance Dosage valproic acid 500 mg ATC: N03AG01
Manufacturer: G.L. Pharma GmbH
-
The medicine is used in adults and children to treat various forms of epilepsy, including generalized seizures and partial seizures.
Form: syrup
Active substance Dosage sodium valproate 50 mg/ml valproic acid 4.338 g sodium chloride 0.04 g ATC: N03AG01
Manufacturer: G.L. Pharma GmbH
-
The medicine is used in the treatment of epilepsy (various forms) and mania occurring in bipolar affective disorder.
Form: capsules, soft gelatin
Active substance Dosage valproic acid 150 mg ATC: N03AG01
Manufacturer: G.L. Pharma GmbH
-
The medicine is used in the treatment of epilepsy (various forms) and mania occurring in bipolar disorder.
Form: capsules, soft gelatin
Active substance Dosage valproic acid 300 mg ATC: N03AG01
Manufacturer: G.L. Pharma GmbH
-
The medicine is used to treat epilepsy (various forms) and mania occurring in bipolar disorder.
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 200 mg valproic acid 87 mg ATC: N03AG01
Manufacturer: Sanofi Aventis S.A. Sanofi Winthrop Industry
-
The medicine is used in the treatment of epilepsy (various forms) and mania occurring in bipolar disorder.
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 333 mg valproic acid 145 mg ATC: N03AG01
Manufacturer: Sanofi-aventis Monoprósopi S.A.
-
It is used in the treatment of epilepsy (various forms) and mania occurring in bipolar disorder.
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 333 mg valproic acid 145 mg ATC: N03AG01
Manufacturer: Sanofi-aventis Monoprósopi S.A.
-
The medicine is used to treat epilepsy (various types of seizures) and mania occurring in bipolar disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 66.66 mg valproic acid 29.03 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicine is used to treat epilepsy (different types of seizures) and mania occurring in bipolar disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 666.6 mg valproic acid 290.27 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicine is used in the treatment of epilepsy (various types of seizures) and mania occurring in bipolar disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 166.76 mg valproic acid 72.61 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicine is used to treat epilepsy (various types of seizures) and mania occurring in bipolar disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 333.3 mg valproic acid 145.14 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicinal product is used in the treatment of epilepsy (various types of seizures, including myoclonic, tonic-clonic, atonic, as well as West syndrome and Lennox-Gastaut syndrome) and in the treatment of mania occurring in bipolar affective disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 500.06 mg valproic acid 217.75 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicinal product is used in the treatment of epilepsy (in its various forms) and in the treatment of mania occurring in the course of a condition called bipolar disorder.
Form: tablets, prolonged release
Active substance Dosage valproic acid No input provided sodium valproate No input provided ATC: N03AG01
Manufacturer: HEXAL A/S Lek Pharmaceuticals d.d. LEK S.A. Salutas Pharma GmbH
-
The medicinal product is used in the treatment of epilepsy (in its various forms) and in the treatment of mania occurring in bipolar disorder.
Form: tablets, prolonged release
Active substance Dosage valproic acid No input provided sodium valproate No input provided ATC: N03AG01
Manufacturer: HEXAL A/S Lek Pharmaceuticals d.d. LEK S.A. Salutas Pharma GmbH